Skip to main content

Advertisement

SpringerLink
Log in

Research funding, partnership and strategy — a UK perspective

  • Science and Society
  • Published:

From Nature Reviews Molecular Cell Biology

View current issue Sign up to alerts

Abstract

In July 2004, the UK government published a 10-year science and innovation framework aimed at providing a more strategic, partnership-based approach to delivering science. With the aim of creating a UK society that is confident about the governance, regulation and use of science and technology, how can we sustain or increase the supply of money for research, how should funding agencies dispense money, and how can we optimize the partnership arrangements for the funding of research?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Vannevar Bush (1890–1974).

References

  1. Bush, V. Science The Endless Frontier: A Report to the President by Vannevar Bush, Director of the Office of Scientific Research and Development, July 1945. (US Government Printing Office, Washington DC, 1945).

    Book  Google Scholar 

  2. HM Treasury, Department of Trade and Industry, Department for Education and Skills. Science & Innovation Investment Framework, 2004–2014. (Her Majesty's Stationery Office, London, 2004).

  3. Comroe, J. H. & Dripps, R. D. Scientific basis for the support of biomedical science. Science 192, 105–111 (1976).

    Article  Google Scholar 

  4. Druker, B. J. & Lydon, N. B. Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J. Clin. Invest. 105, 3–7 (2000).

    Article  CAS  Google Scholar 

  5. Feldmann, M. & Maini, R. N. Anti-TNFα therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19, 163–196 (2001).

    Article  CAS  Google Scholar 

  6. Comroe, J. H. & Dripps, R. D. The Top Ten Clinical Advances in Cardiovascular–Pulmonary Medicine and Surgery, 1945–1975. Final Report. (US Government Printing Office, Washington DC, 1977).

    Google Scholar 

  7. Grant, J., Green, L. & Mason, B. From bedside to bench: Comroe and Dripps revisited. HERG Research Report 30, 48 (2003).

    Google Scholar 

  8. Lederberg, J. Fifty years of biochemical genetics: a tribute. The Scientist 5, 12 (1991).

    Google Scholar 

  9. Brenner, S. The impact of society on science. Science 282, 1411 (1998).

    Article  Google Scholar 

  10. Klausner, R. et al. Medicine. The need for a global HIV vaccine enterprise. Science 300, 2036–2039 (2003).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. the Wellcome Trust, 215 Euston Road, London, NW1 2BE, UK

    Mark J. Walport & David W. Lynn

Authors
  1. Mark J. Walport
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David W. Lynn
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

FURTHER INFORMATION

Department for Education and Skills

Department of Health

Department of Trade and Industry

Grand Challenges in Global Health

HM Treasury

Office of Science and Technology

Research Councils UK

Science The Endless Frontier

Scientific Basis for the Support of Biomedical Science

Universities UK

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walport, M., Lynn, D. Research funding, partnership and strategy — a UK perspective. Nat Rev Mol Cell Biol 6, 341–344 (2005). https://doi.org/10.1038/nrm1617

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrm1617

  • Springer Nature Limited

This article is cited by

Search

Navigation